Get in Touch

Sleep Apnea

Blue Ocean MedTech (BOMT) is guided by the mission of “bringing healing to doorstep” and brings products and solutions for diagnosis, treatment and monitoring of wide range of breathing disorders like Obstructive Sleep Apnea( OSA)/ Sleep Disordered Breathing (SDB) and Chronic respiratory disorders like Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD) etc.

We are the associated partners of leading healthcare companies like Sefam Heath Tech of France , Breas Medical of Sweden, Vitelograph of UK , Clevemed USA… in the domain of diagnosis and treatment of respiratory diseases. We have wide network of coverage Our objective is offer best of technology and solutions , so that clinicians can treat and take care of the patients with best clinical outcome.

Select options to learn more on the Obstructive Sleep Apnea (OSA) or Sleep Disordered Breathing (SDB) and chronic respiratory disorders alongwith BOMT’s diagnosis and treatment options.

Obstructive Sleep Apnea (OSA)

Blue Ocean Medtech provides solutions for screening, diagnosis, treatment and continuous monitoring of patients suffering from Obstructive Sleep Apnea (OSA) or Sleep Disordered Breathing (SDB)

Select options to learn more about Obstructive Sleep Apnea and associated co-morbidities like Type 2 Diabetes, Secondary Hypertension

Common symptoms of sleep disorders

The most common symptoms of OSA or SDB are loud snoring associated with excessive daytime sleepiness. However these symptoms are generally ignored by most people as signs of sleep disorder and they fail to report these to their physicians.

Other symptoms of OSA/ SDB are 1:

  • Gasping or choking during sleep
  • Dry mouth or sore throat in the morning
  • Morning Headache
  • Witnessed pauses in breathing during sleep
  • Lack of concentration
  • Depression
  • Irritative behaviour
  • Daytime Fatigue
  • Forgetfulness
  • Sexual Dysfunction
  • Regular weight gain
  • Frequent urination at night (Nocturia)

It is very important to identify the common symptoms of OSA/ SDB and
discuss with your physician. The physician will advice you about the
potential risk of sleep apnea and will advice you to undergo a sleep test at
home.

Risk factors of untreated Sleep Apnea

Obesity:

  • Sleep deprivation or diminishing quality of sleep increases appetitefor high calorie food
  • 90% of obese male and 50% of obese females are estimated to have OSA
  • Incidence of OSA is directly related to increase in Body Mass Index (BMI)
  • About 80% of patients with OSA weight 130% or more of their ideal body weight

Cardiac Arrhythmias :

  • Untreated OSA leads to 4 times the chance of developing Atrial Fibrillation which is a very dangerous arrhythmia and can lead to adverse events like stroke.

Type 2 Diabetes:

  • Untreated sleep apnea leads to poor insunil control and poorly controlled blood sugars
  • 58% of patients with Type 2 Diabetes estimated to have OSA
  • 86% of Obese patients with type 2 diabetes suffer from OSA

Secondary Hypertension:

  • OSA is leading cause of secondary hypertension (High Blood Pressure)
  • Blood pressure dips at night in normal persons , whereas in patients with OSA , blood pressure doesn’t dip
  • Resistant Hypertension, absence of nocturnal decrease in BP and Obesity are often simultaneously present in patients with OSA

Mood Disturbance:

Untreated OSA can lead to

  • Depression
  • Anxiety
  • Loss of Motivation
  • Shortened attention span
  • Moodiness and bad temper
  • Poor judgement

Stroke:

  • Men with moderate to severe OSA are nearly 3 times more likely to have stroke
  • OSA is often found in patients following a stroke
  • Risk of stroke rises with severity of OSA

Accident and Workplace Inefficiency:

  • Excessive daytime sleepiness leads to 6 fold increase in risk of car accidents
  • Reduced alertness, impaired concentration, memory loss, daytime sleepiness , fatigue can affect workplace efficiency and productivity

Sleep apnea treatment options

Treatment of OSA may require multipronged approach starting with patient education and might include medical or surgical interventions

Positive airway pressure (PAP) therapy

Positive Airway Pressure (PAP) therapy is considered to be the gold standard approach to treat OSA or SDB. Pressurized air is sent from a therapy device through patient tubing and non invasive masks worn by patients covering nose (Nasal) or both nose and mouth (Oro Nasal). Positive pressure created by pressurised air in upper airway prevents the soft tissues of the upper airway to narrow or collapse. Prevention of upper airway narrowing or collapse addresses snoring, flow limitation and obstructive apnea thereby maintaining the oxygenation level optimally and adequately. As a result of PAP therapy a patient with OSA is most likely to return to normal sleep pattern and restore the normal quality of sleep with his or her sleep deprivation getting resolved.

Different types of PAP therapy

Positive airway pressure therapy can be delivered in a number of modes:

  • Continuous positive airway pressure (CPAP) – a fixed CPAP device which delivers pressurized air at a fixed pressure which is determined by running trial on the patient to titrate with the optimal pressure required to prevent upper airway narrowing and collapse,
  • Automatic positive airway pressure (APAP) therapy – A Positive Airway Pressure which automatically adjusts the pressure as per the breathing patterns of the patient. The optimum pressure to keep the upper airway open varies from night to night and the APAP device automatically adjusts to the varying needs of the optimum pressure night to night. So the APAP device is likely to be more comfortable for the patient and should be ensuring better compliance to the PAP therapy. The APAP is also maybe suitable for specific conditions like non-compliance with the fixed CPAP, sleep apnea during REM (Rapid Eye Movement)phase and for patients having positional aplnea.
  • Bilevel or BIPAP or Dual Pressure therapy – a device which provides dual pressure levels – Lower End Expiratory Positive Airway Pressure (EPAP) and Higher Inspiratory Positive Airway Pressure (IPAP). This therapy is effective for patients who are non-compliant with APAP/ CPAP and patients with concomitant respiratory disorder like chronic obstructive lung diseases , Obesity Hypoventilation etc.

Oral appliance therapy

Mandibular Advancement Device (MAD), is a type of oral device is a adjustable oral appliance that ensures lower jaw in a forward position while sleeping. This can be a second line of therapy for mild to moderate sleep apnea. The Mandibular Advancement expands the space behind tongue, creates tension on the pharyngeal muscles, thereby reducing collapse of upper airway soft tissue and reduces vibration of palate.

Alternative treatment options

Another option is surgery, a surgical procedure called Uvulopalatopharyngoplastry (UPPP) , used to treat primarily snoring or OSA. However the surgical option is not recommended as the first line of treatment because of associated risks and also chances of recurrence.

 

References

01 : Weaver T.E., et al. 2007 “Relationship between hours of CPAP Use and Achieving Normal levels of Sleepiness and Daily Function” Sleep, vol. 30, No. 6, pp. 711-719 

02 : Epstein L.J., et al. 2009 ‘Clinical Guideline for the Evaluation, amangement and long-term Care of Obstructive Sleep Apnea in Adults” Journal of Clinical Sleep Medicine, vol. 5, no. 3 pp. 263-276. 

03 : Effects and Side-Effects of Surgery for Snoring and Obstructive Sleep Apnea- A systematic Review (SLEEP, vol. 32, no.1 2009. 

04 : Hillman D.R., Lack L.C., 2013 ‘Public Health implications of sleep loss: the community burden’ Medical Journal of Australia vol. 199, no. 8 pp. S7-S10 

05 : Palnitkar G., Zimmermann S.C., & Cistulli P.A. 2012 ‘Obstructive Sleep Apnoea in adults: Identifying risk factors and tailoring therapy’, MedicineToday, vol. 13, no. 8, pp. 14-23.

06 : Hillman D.R., Lack L.C., 2013 ‘Public Health implications of sleep loss: the community burden’ Medical Journal of Australia vol. 199, no. 8 pp. S7-S10 

07 : Stuuts J et al. Driver risk factors for sleep-related crashes. Accident Analysis and Prevention 35 2003

08 : Ward K.L., et al. ‘Excessive Daytime Sleepiness Increases the risk of motor vehicle crash in Obstructive Sleep Apnea’ Journal of Clinical Sleep Medicine, 2013, vol. 9, no. 10 pp. 1013-1021

09 : Tregear S., Et al. ‘Obstructive Sleep Apnea and Risk of motor Vehicle Crash:Systematic Review and Meta-Analysis’ Journal of Clinical Sleep Medicine, 2009, vol. 5, no. 6 pp. 573-581 

10 : Punjabi N.M., 2008 “The Epidemiology of Adult Obstructive Sleep Apnea” American Thoracic Society Journal, vol. 5, pp. 136-143.

11 : Bradley, T.B., & Floras J.S. 2009 ‘Obstructive Sleep Apnoea and its cardiovascular consequences’ Lancet, vol. 373, pp. 82-93. 

Obstructive Sleep Apnea (OSA)

BOMT provides solutions for screening, diagnosis, treatment and continuous monitoring of patients suffering from Obstructive Sleep Apnea (OSA) or Sleep Disordered Breathing (SDB).

Select options to learn more about Obstructive Sleep Apnea and associated co-morbidities like Type 2 Diabetes, Secondary Hypertension

Central Sleep Apnea

Central Sleep Apnoea (CSA) is the least common type of sleep apnoea.  Scientists say that less than 20 percent of all cases of sleep apnoea  are diagnosed as CSA.

Unlike Obstructive Sleep Apnoea, Central Sleep Apnoea can occur while your airway is clear. CSA means you stop breathing for 10 seconds or more during sleep because your brain fails to send signals for your body to inhale. 

Cheyne-Strokes Respiration (CSR)

Coming Soon

Mixed Apnea (MA)

Coming Soon